Pregnancy in a Series of Dystonia Patients Treated with Deep Brain Stimulation: Outcomes and Management RecommendationsZiman N.a · Coleman R.R.a · Starr P.A.b · Volz M.a · Marks Jr. W.J.a · Walker H.C.c, d · Guthrie S.L.c · Ostrem J.L.a
aDepartment of Neurology, University of California, San Francisco, Movement Disorder and Neuromodulation Center, and bDepartment of Neurological Surgery, University of California, San Francisco, San Francisco, Calif., and Departments of cNeurology and dBiomedical Engineering, University of Alabama at Birmingham, Birmingham, Ala., USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Background: Medically refractory dystonia affects children and young adults, and deep brain stimulation (DBS) can allow some patients to regain functional independence. Women with dystonia treated with DBS may wish to conceive a child, but there is limited published information on pregnancy and DBS. Objective: To describe a series of dystonia patients treated with DBS who later became pregnant and provide guidelines for women treated with DBS considering conception. Methods: We reviewed all dystonia DBS cases implanted at the University of California, San Francisco, and University of Alabama at Birmingham from 1998 to 2015 and identified patients who became pregnant. Patient records were reviewed and structured interviews were conducted. Results: Six dystonia patients were identified [1 currently pregnant and 7 live births (including 1 twin pair)]. Patients (n = 5) with pre- and postoperative BFMDRS (Burke-Fahn-Marsden Dystonia Rating Scale) scores improved by 65.9% after DBS. All pregnancies and deliveries were uncomplicated (the delivery mode was not influenced by the presence of DBS), except for 1 child, who was born premature at 35 weeks' gestation. Stimulation remained on (n = 3) or off (n = 4) during deliveries. DBS neurostimulators did not hinder breastfeeding. Conclusions: In this small sample, pregnancy, delivery, and breastfeeding were safe in dystonia patients treated with DBS. The presence of DBS should not be a contraindication to pregnancy.
© 2016 S. Karger AG, Basel
- Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, Hallett M, Jankovic J, Jinnah HA, Klein C, Lang AE, Mink JW, Teller JK: Phenomenology and classification of dystonia: a consensus update. Mov Disord 2013;28:863-873.
- Page D, Butler A, Jahanshahi M: Quality of life in focal, segmental, and generalized dystonia. Mov Disord 2007;22:341-347.
- Mills KA, Starr PA, Ostrem JL: Neuromodulation for dystonia: target and patient selection. Neurosurg Clin N Am 2014;25:59-75.
- Hariz GM, Limousin P, Tisch S, Jahanshahi M, Fjellman-Wiklund A: Patients' perceptions of life shift after deep brain stimulation for primary dystonia - a qualitative study. Mov Disord 2011;26:2101-2106.
Medtronic: Important safety information. http://www.medtronic.com/patients/dystonia/ important-safety-information/index.htm (accessed December 12, 2014).
- Paluzzi A, Bain PG, Liu X, Yianni J, Kumarendran K, Aziz TZ: Pregnancy in dystonic women with in situ deep brain stimulators. Mov Disord 2006;21:695-698.
- Fedoroff IC, Blackwell E, Malysh L, McDonald WN, Boyd M: Spinal cord stimulation in pregnancy: a literature review. Neuromodulation 2012;15:537-541; discussion 541.
- Edelbroek C, Terheggen M: High-frequency spinal cord stimulation and pregnancy: a case report. Neuromodulation 2015;18:757-758.
- Young AC, Lubenow TR, Buvanendran A: The parturient with implanted spinal cord stimulator: management and review of the literature. Reg Anesth Pain Med 2015;40:276-283.
- Grabli D, Ewenczyk C, Coelho-Braga MC, Lagrange C, Fraix V, Cornu P, Benabid AL, Vidailhet M, Pollak P: Interruption of deep brain stimulation of the globus pallidus in primary generalized dystonia. Mov Disord 2009;24:2363-2369.
- Charles D, Konrad PE, Davis TL, Neimat JS, Hacker ML, Finder SG: Deep brain stimulation in early stage Parkinson's disease. Parkinsonism Relat Disord 2015;21:347-348.
- Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, et al; EARLYSTIM Study Group: Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med 2013;368:610-622.
- Hariz M, Blomstedt P, Zrinzo L: Future of brain stimulation: New targets, new indications, new technology. Mov Disord 2013;28:1784-1792.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.